Cargando…

Neoadjuvant and adjuvant therapy for gastrointestinal stromal tumors

Gastrointestinal stromal tumors (GIST) are rare and mesenchymal in origin with a yearly incidence of 10‐15 cases per million people. If it is technically resectable, surgical resection is the mainstay of therapy regardless of tumor location,. Although complete (R0) resection can be achieved in up to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Iwatsuki, Masaaki, Harada, Kazuto, Iwagami, Shiro, Eto, Kojiro, Ishimoto, Takatsugu, Baba, Yoshifumi, Yoshida, Naoya, Ajani, Jaffer A., Baba, Hideo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Review Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6345649/ https://www.ncbi.nlm.nih.gov/pubmed/30697609 http://dx.doi.org/10.1002/ags3.12211

Ejemplares similares

Multiple heterochronic gastrointestinal stromal tumors in the stomach detected 6 years after resection: a case report
por: Yasuda, Tadahito, et al.
Publicado: (2020)

Can PD-L1 expression evaluated by biopsy sample accurately reflect its expression in the whole tumour in gastric cancer?
por: Yamashita, Kohei, et al.
Publicado: (2019)

Surgical treatment for gastrointestinal neuroendocrine tumors
por: Eto, Kojiro, et al.
Publicado: (2020)

Trastuzumab upregulates programmed death ligand-1 expression through interaction with NK cells in gastric cancer
por: Yamashita, Kohei, et al.
Publicado: (2020)

Evaluation of clinical outcomes with propensity‐score matching for colorectal cancer presenting as an oncologic emergency
por: Ogawa, Katsuhiro, et al.
Publicado: (2022)

Clinical Significance of Pretreatment Red Blood Cell Distribution Width as a Predictive Marker for Postoperative Morbidity After Esophagectomy for Esophageal Cancer: A Retrospective Study
por: Yoshida, Naoya, et al.
Publicado: (2021)

Prognostic Value of Pretreatment Red Blood Cell Distribution Width in Patients With Esophageal Cancer Who Underwent Esophagectomy: A Retrospective Study
por: Yoshida, Naoya, et al.
Publicado: (2022)

Immune-related adverse events and prognosis in patients with upper gastrointestinal cancer treated with nivolumab
por: Hara, Yoshihiro, et al.
Publicado: (2022)

Fusobacterium nucleatum confers chemoresistance by modulating autophagy in oesophageal squamous cell carcinoma
por: Liu, Yang, et al.
Publicado: (2020)

Laparoscopic surgery for colorectal cancer with persistent descending mesocolon
por: Hiyoshi, Yukiharu, et al.
Publicado: (2019)

Indoleamine 2, 3‐dioxygenase 1 promoter hypomethylation is associated with poor prognosis in patients with esophageal cancer
por: Kiyozumi, Yuki, et al.
Publicado: (2019)

KRAS and BRAF Mutations in 203 Esophageal Squamous Cell Carcinomas: Pyrosequencing Technology and Literature Review
por: Shigaki, Hironobu, et al.
Publicado: (2012)

Lysyl oxidase impacts disease outcomes and correlates with global DNA hypomethylation in esophageal cancer
por: Kalikawe, Rebecca, et al.
Publicado: (2019)

Precautions for avoiding pulmonary morbidity after esophagectomy
por: Yoshida, Naoya, et al.
Publicado: (2020)

LINE-1 hypomethylation in gastric cancer, detected by bisulfite pyrosequencing, is associated with poor prognosis
por: Shigaki, Hironobu, et al.
Publicado: (2012)

Synchronous NET and colorectal cancer development: a case report
por: Yumoto, Shinsei, et al.
Publicado: (2020)

Port site recurrence of esophageal adenocarcinoma after minimally invasive esophagectomy: a case report
por: Horino, Taichi, et al.
Publicado: (2020)

Tumor immune microenvironment and immune checkpoint inhibitors in esophageal squamous cell carcinoma
por: Baba, Yoshifumi, et al.
Publicado: (2020)

Multiple skeletal muscle metastases from poorly differentiated gastric adenocarcinoma
por: Koga, Yuki, et al.
Publicado: (2015)

Programmed death ligand‐1 expression in gastrointestinal cancer: Clinical significance and future challenges
por: Yamashita, Kohei, et al.
Publicado: (2020)

Thyroid metastasis from esophageal adenocarcinoma: a case report and literature review
por: Yumoto, Shinsei, et al.
Publicado: (2019)

Clinical impact of perirenal thickness on short‐ and long‐term outcomes of gastric cancer after curative surgery
por: Eto, Kojiro, et al.
Publicado: (2022)

Prognostic and clinical impact of PD-L2 and PD-L1 expression in a cohort of 437 oesophageal cancers
por: Okadome, Kazuo, et al.
Publicado: (2020)

Recent advances in treating oesophageal cancer
por: Harada, Kazuto, et al.
Publicado: (2020)

Identification of miR-30e* Regulation of Bmi1 Expression Mediated by Tumor-Associated Macrophages in Gastrointestinal Cancer
por: Sugihara, Hidetaka, et al.
Publicado: (2013)

Glucose transporter 1 regulates the proliferation and cisplatin sensitivity of esophageal cancer
por: Sawayama, Hiroshi, et al.
Publicado: (2019)

Co-occurrence of liver metastasis of gastrointestinal stromal tumor and hepatocellular carcinoma: a case report
por: Yamashita, Kohei, et al.
Publicado: (2016)

IgG4-related disease presenting as a submucosal tumor of the stomach resected with laparoscopic endoscopic cooperative surgery: a case report
por: Yamane, Taishi, et al.
Publicado: (2020)

Adapted systemic inflammation score as a novel prognostic marker for esophageal squamous cell carcinoma patients
por: Nomoto, Daichi, et al.
Publicado: (2021)

A case of clinical stage I gastric cancer with a schwannoma on the left supraclavicular fossa suspected as Virchow’s node metastasis
por: Hara, Yoshihiro, et al.
Publicado: (2022)

PD‐L1 and PD‐L2 expression status in relation to chemotherapy in primary and metastatic esophageal squamous cell carcinoma
por: Okadome, Kazuo, et al.
Publicado: (2021)

Pan-immune-inflammation Value and Prognosis in Patients With Esophageal Cancer
por: Baba, Yoshifumi, et al.
Publicado: (2021)

TET family proteins and 5-hydroxymethylcytosine in esophageal squamous cell carcinoma
por: Murata, Asuka, et al.
Publicado: (2015)

Recent trend in gastric cancer treatment in the USA
por: Harada, Kazuto, et al.
Publicado: (2018)

UHRF1 regulates global DNA hypomethylation and is associated with poor prognosis in esophageal squamous cell carcinoma
por: Nakamura, Kenichi, et al.
Publicado: (2016)

Relationship between Fusobacterium nucleatum and antitumor immunity in colorectal cancer liver metastasis
por: Sakamoto, Yuki, et al.
Publicado: (2021)

Review of the gut microbiome and esophageal cancer: Pathogenesis and potential clinical implications
por: Baba, Yoshifumi, et al.
Publicado: (2017)

Frequency of HER2 expression of circulating tumour cells in patients with metastatic or recurrent gastrointestinal cancer
por: Iwatsuki, M, et al.
Publicado: (2013)

Prognostic and clinical impact of PIK3CA mutation in gastric cancer: pyrosequencing technology and literature review
por: Harada, Kazuto, et al.
Publicado: (2016)

Conflicting metabolic alterations in cancer stem cells and regulation by the stromal niche
por: Yasuda, Tadahito, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_v1hg8n986iq0rnpt3lrtc0qrs2